Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models
- 1 November 2010
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 120 (11), 3940-3952
- https://doi.org/10.1172/jci44165
Abstract
KRAS is one of the most frequently mutated human oncogenes. In some settings, oncogenic KRAS can trigger cellular senescence, whereas in others it produces hyperproliferation. Elucidating the mechanisms regulating these 2 drastically distinct outcomes would help identify novel therapeutic approaches in RAS-driven cancers. Using a combination of functional genomics and mouse genetics, we identified a role for the transcription factor Wilms tumor 1 (WT1) as a critical regulator of senescence and proliferation downstream of oncogenic KRAS signaling. Deletion or suppression of Wt1 led to senescence of mouse primary cells expressing physiological levels of oncogenic Kras but had no effect on wild-type cells, and Wt1 loss decreased tumor burden in a mouse model of Kras-driven lung cancer. In human lung cancer cell lines dependent on oncogenic KRAS, WT1 loss decreased proliferation and induced senescence. Furthermore, WT1 inactivation defined a gene expression signature that was prognostic of survival only in lung cancer patients exhibiting evidence of oncogenic KRAS activation. These findings reveal an unexpected role for WT1 as a key regulator of the genetic network of oncogenic KRAS and provide important insight into the mechanisms that regulate proliferation or senescence in response to oncogenic signals.Keywords
This publication has 62 references indexed in Scilit:
- The Wilms' Tumor Suppressor Protein WT1 Is Processed by the Serine Protease HtrA2/OmiMolecular Cell, 2010
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1Nature, 2009
- A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras OncogeneCell, 2009
- c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolismNature, 2009
- CDK8 is a colorectal cancer oncogene that regulates β-catenin activityNature, 2008
- Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation studyNature Medicine, 2008
- A negative feedback signaling network underlies oncogene-induced senescenceCancer Cell, 2006
- A loss-of-function RNA interference screen for molecular targets in cancerNature, 2006
- Oncogenic pathway signatures in human cancers as a guide to targeted therapiesNature, 2005
- Mutations of the BRAF gene in human cancerNature, 2002